MON-148 Weight Gain in Patients with Acromegaly after Pituitary Surgery: Predictive Factors and Insights - A Large Single Center Experience
Notice bibliographique
Résumé
Abstract M. Stack: None. E.V. Varlamov: Grant Recipient; Self; Pfizer, Inc., Lumiio, Recordati. D.S. Lim: None. F. Langlois: Consulting Fee; Self; Recordati, Ipsen. M. Fleseriu: Consulting Fee; Self; Amryt, Camurus, Crinetics, Ipsen, Recordati. Grant Recipient; Self; Amryt, Crinetics, Ionis Pharmaceuticals Inc., Recordati. Background: Excessive growth hormone (GH) and insulin-like growth factor 1 (IGF-1) in patients (pts) with acromegaly (acro) leads to skeletal overgrowth and metabolic changes. GH lipolytic effect ↑ lean body mass, ↓ fat mass, and ↑ insulin resistance. Partial reversal of such changes can occur after GH adenoma surgery. At follow-up (f/u), weight outcomes postoperatively (postop) vary in studies from no change to significant weight gain. Objective: Enhance understanding and identify predictors of postop weight changes in pts with acro. Design & Method: IRB approved retrospective review of pts with acro who underwent pituitary surgery at OHSU (2006-2022) with >12 months (mo) f/u. Excluded: pts who started/stopped weight- altering drugs or were in a weight loss program (3 mo pre- to 12 mo postop), pregnancy, and uncontrolled hyper/hypothyroidism. Age, sex, weight, BMI, IGF-1, GH, pituitary function status, HbA1C, comorbidities, and medications were recorded. Data analysis: SPSS29, Excel. Results: 15 pts were excluded, for a final cohort of 93 pts (53 females), age 45.4 ± 17.1 years, BMI 29.5 ± 6.5 kg/m2, mean f/u 44.4 ± 23.5 mo. 53 pts were in remission at 12 mo. 65% gained weight at 12 mo postop; 43% > 3% and 32% > 5%. Mean weight gain was 2.6 ± 7.2 kg (2.7%) from baseline to 12 mo postop (89.9 ± 23.9 vs 92.5 ± 26.4 kg, p < 0.001), with no significant sex-based differences at 3, 6, and 12 mo f/u. Age, preop BMI, preop GH, preop IGF-1xULN, % ↓ in IGF-1, acro remission status, pituitary deficiencies, DM2, hyperlipidemia, hypertension and obstructive sleep apnea were not significantly associated with weight gain at 6 and 12 mo. Females with > 3% weight gain had higher preop IGF-1xULN vs those with < 3% weight gain at both 6 (p = 0.036) and 12 mo (p = 0.01). No difference in weight gain at 12 mo was observed in treatment-naïve vs previously treated pts. Postop medications for acro were not associated with weight change at 6 and 12 mo. Weight gain tended to be higher in pts with pituitary surgery pre-2016 (3.8% vs 1.3%, p = 0.057).Discussion: This large single center study highlights that 65% pts with acro gained weight at 12 mo postop, with a noteworthy proportion gaining > 3% and 5%. Weight gain is relatively similar with previous reports: 1-3 kg in pts with surgical/medical remission. Among multiple factors examined, higher preop IGF-1 was associated with weight gain in females only. The mechanism of observed sex difference needs further study. Pts with surgery since 2016 tended to gain less weight, possibly due to proactive discussion with pts of weight gain risk at our Center. Conclusion: Our findings emphasize a risk of significant postop weight gain in pts with acro; in females, weight gain of > 3 % was associated with preop IGF-1 levels. Given that obesity increases cardiovascular risk, lifestyle or pharmacological methods to prevent weight gain after pituitary surgery should be actively considered. Monday, June 3, 2024
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,000 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».